跳至主要内容
临床试验/NCT06236633
NCT06236633招募中不适用

Evaluation of the Safety and Efficacy of Ischemic Preconditioning by Embolization of the Inferior Mesenteric Artery in Oncologic Surgery for Tumors of the Lower and Middle Rectum. Bicentric Exploratory Pilot Study

Centre Hospitalier Universitaire de Nīmes6 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年8月2日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30
试验地点
6
主要终点
Safety of endovascular inferior mesenteric artery embolisation prior to surgical resection of the rectum in patients with tumours of the lower and middle rectum.

研究概览

简要总结

The present study will investigate the safety of inferior mesenteric artery embolization prior to rectal surgery, according to IDEAL recommendations (Lancet 2009). It aims to assess the safety of endovascular embolization of the inferior mesenteric artery prior to surgery in patients with rectal tumors, and estimate the potential benefits in terms of time to surgery and the occurrence of post-operative fistulas.The study will also assess the impact of subacute ischemia induced by IMA embolization on colonic vasculature remodeling, colonic ischemic suffering, altered hemostasis and initiation of neo-angiogenesis through blood sampling kinetics.The hypothesis is that ischemic preconditioning by inferior mesenteric artery embolization prior to rectal cancer resection surgery is safe and will result in a decrease in acute relative colon ischemia and a reduction in the rate of fistulas and post-surgical complications. Indeed, we believe that the beneficial effects of the ischemic preconditioning of IMA will be due to better blood perfusion of the colon at 3 weeks, which is apparently linked to remodeling and/or the development of collateral vascularization.

详细描述

Anastomotic fistulas are the main cause of morbidity and mortality in colorectal surgery. They are responsible for septic complications, leading to increased mortality, local recurrence, repeat surgery and impaired sexual, urinary and digestive function. Fistulas are multifactorial; among the causes, colonic vascularization seems to be a major one. Ligation of the inferior mesenteric artery during rectal surgery has been shown to reduce intraoperative colonic perfusion flow. The left colon is then vascularized only by the colonic border arcade, perfused by the superior mesenteric artery. Ischemic pre-conditioning of the arterial network prior to surgery should ensure better vascularization by developing arterial collaterality and increasing perfusion flow in the colonic border arcade. In view of major advances in interventional radiology, this preconditioning could be achieved by endovascular ligation of the inferior mesenteric artery (IMA), based on the same principle as during surgery: proximal occlusion of the inferior mesenteric artery (IMA), using embolization material (plug or coils), 3 weeks before surgery, to allow the colonic border arcade to develop. We carried out a single-center pilot study (AMIREMBOL 1, NIMAO 2017; Frandon et al. 2022) to assess the feasibility of ischemic preconditioning of the colon for patients with rectal or sigmoid cancer. The study included 10 patients, randomized into two groups: the control group, with preoperative arteriography and standard management and the "embolization" group, with embolization of the IMA three weeks prior to surgery. IMA embolization was successfully performed in all 5 patients in the embolization group, with no major complications. The effect on colonic perfusion, measured by intraoperative Doppler directly on the border arch, with recording of resistance indexes (independent of measurement angle), showed a drop in resistance indexes in the control arm, after ligation of the IMA, which persisted after 5 minutes. In the "Embolization" arm, no drop in this index was reported during surgery, reflecting good development of vascular collaterality and at least relative acute ischemia of the colon after IMA ligation during surgery. Finally, in the "control" group, one anastomotic fistula was reported after surgery and required re-operation. There were no fistulas in the embolization group.

The present study (AMIREMBOL 2) will investigate the safety of IMA embolization prior to rectal surgery, according to IDEAL recommendations (Lancet 2009). Its aim is to assess the safety of endovascular embolization of the IMA prior to surgery in patients with rectal tumors, and to estimate the potential benefits in terms of time to surgery and the occurrence of post-operative fistulas.

The study will also assess the impact of subacute ischemia induced by IMA embolization on colonic vasculature remodeling, colonic ischemic suffering, altered hemostasis and initiation of neo-angiogenesis through blood sampling kinetics.

The hypothesis is that ischemic preconditioning by inferior mesenteric artery (IMA) embolization prior to rectal cancer resection surgery is safe and will result in a decrease in acute relative colon ischemia and a reduction in the rate of fistulas and post-surgical complications. The hypothesis is that the beneficial effects of the ischemic preconditioning of IMA will be due to better blood perfusion of the colon at 3 weeks, which is apparently linked to remodeling and/or the development of collateral vascularization.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

盲法说明

Due to the type of intervention and the design of the study, the patient and the referring caregivers cannot be blinded.

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with rectal cancer eligible for surgery with ligation at the origin of the inferior mesenteric artery.
  • Patients with free, informed consent.
  • Patients affiliated to or benefiting from a health insurance plan.

排除标准

  • Patients with a history of colon cancer who has undergone colon resection surgery
  • Patients with occlusion of the superior mesenteric artery or stenosis of more than 50%, visible on the CT scan performed as part of conventional management during extension workup.
  • Patients with occlusion of the IMA on the extension scan.
  • Patients with a systemic disorder responsible for haemostasis (haemophilia, Willebrand's disease, thrombocytopenia) and on anticoagulant therapy.
  • Patients taking corticosteroids or immunosuppressants leading to an unacceptable surgical risk.
  • Patients with renal insufficiency with clearance < 30mL/min.
  • Patients with an allergy to iodine.
  • Patients who has had treatment of the abdominal aorta or its branches.
  • Patients participating in an interventional study.
  • Patients in an exclusion period determined by another study.
  • Patients under court protection, guardianship or curatorship.
  • Patients unable to give consent.
  • Patients for whom it is impossible to provide informed information.
  • Pregnant or breast-feeding patients.

结局指标

主要结局

Safety of endovascular inferior mesenteric artery embolisation prior to surgical resection of the rectum in patients with tumours of the lower and middle rectum.

时间窗: Day 7 post embolization (performed 3 weeks before surgical resection of the rectum)

Percentage of patients with a complication (any grade) within 7 days after embolisation of the inferior mesenteric artery according to the classification of the International Society of Interventional Radiology assessed during the follow-up telephone consultation by the interventional radiologist. Complications will be classified as minor (Grades A and B) or Major (grades C to F). Grade A = No therapy, no consequence Grade B = Nominal therapy, no consequence. Includes overnight admission for observation only Grade C = Requires therapy, minor hospitalization (\<48 hours) Grade D = Requires major therapy. Unplanned increase in level of care. Prolonged hospitalization (\>48 hours) Grade E = Permanent adverse sequelae Grade F= Death

次要结局

  • Technical success of the embolization procedure(Day 0, on the day of embolization)
  • Post-surgical complications up to 30 days after surgery. Clavien-Dindo Grade II(Post-operative Day 30)
  • Anti-inflammation markers:(Week 3 to 4 after patient induction just before rectal surgery)
  • Markers of neoangiogenesis : CD34(Week 3 to 4 after patient induction just before rectal surgery)
  • Markers of neoangiogenesis : transcription factor HIF1-α(Week 3 to 4 after patient induction just before rectal surgery)
  • Markers of neoangiogenesis : Growth factors(Week 3 to 4 after patient induction just before rectal surgery)
  • Markers of epithelial-mesenchymal transition : transcription factors(Week 3 to 4 after patient induction just before rectal surgery)
  • Post-surgical complications up to 30 days after surgery. Clavien-Dindo Grade I(Post-operative Day 30)
  • Rate of fistulas up to 30 days after surgery(Post-operative Day 30)
  • Post-surgical complications up to 30 days after surgery. Clavien-Dindo Grade IIIa(Post-operative Day 30)
  • Post-surgical complications up to 30 days after surgery. Clavien-Dindo Grade IVb(Post-operative Day 30)
  • Post-surgical complications up to 30 days after surgery. Clavien-Dindo Grade IVa(Post-operative Day 30)
  • Hemostasis markers : Von Willebrand factor(Week 3 to 4 after patient induction just before rectal surgery)
  • Hemostasis markers : prostaglandin E4(Week 3 to 4 after patient induction just before rectal surgery)
  • Markers of tissue inflammation: L-lactate(Week 3 to 4 after patient induction just before rectal surgery)
  • Markers of tissue inflammation: D-lactate(Week 3 to 4 after patient induction just before rectal surgery)
  • Post-surgical complications up to 30 days after surgery. Clavien-Dindo Grade IIIb(Post-operative Day 30)
  • Systemic inflammation markers: Pro-inflammation cytokines(Week 3 to 4 after patient induction just before rectal surgery)
  • Markers of tissue inflammation: Blood pH(Week 3 to 4 after patient induction just before rectal surgery)
  • Markers of tissue inflammation:intestinal fatty acid-binding protein (I-FABP)(Week 3 to 4 after patient induction just before rectal surgery)
  • Markers of tissue inflammation: Lactate dehydrogenase(Week 3 to 4 after patient induction just before rectal surgery)
  • Markers of epithelial-mesenchymal transition : matrix metallo-protease - 2(Week 3 to 4 after patient induction just before rectal surgery)
  • Post-surgical complications up to 30 days after surgery. Clavien-Dindo Grade V(Post-operative Day 30)
  • Duration of post-surgical hospitalization(Up to 30 days after rectal surgery)
  • Systemic inflammation markers: Complement protein C3(Week 3 to 4 after patient induction just before rectal surgery)
  • Hemostasis markers : coagulation factor V(Week 3 to 4 after patient induction just before rectal surgery)
  • Markers of tissue inflammation: ischemia-modified albumin(Week 3 to 4 after patient induction just before rectal surgery)
  • Hemostasis markers : D-dimers(Week 3 to 4 after patient induction just before rectal surgery)
  • Degree of difficulty experienced by the visceral surgeon during surgery(Week 3 to 4 on the day of rectal surgery)
  • Hemostasis markers : platelet-activating factor (PAF)(Week 3 to 4 after patient induction just before rectal surgery)
  • Hemostasis markers : Thromboxane B2(Week 3 to 4 after patient induction just before rectal surgery)
  • Markers of epithelial-mesenchymal transition : matrix metallo-protease - 9(Week 3 to 4 after patient induction just before rectal surgery)

研究者

发起方
Centre Hospitalier Universitaire de Nīmes
申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验